JP Morgan Chase’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Buy
14,597
+11,420
+359% +$288K ﹤0.01% 5279
2026
Q1
$79.8K Buy
3,177
+3,076
+3,046% +$78.5K ﹤0.01% 5953
2025
Q4
$2.58K Sell
101
-49,982
-100% -$1.28M ﹤0.01% 6906
2025
Q3
$1.28M Buy
+50,083
New +$1.27M ﹤0.01% 4403
2025
Q2
Sell
-904
Closed -$22.6K 7342
2025
Q1
$22.6K Buy
+904
New +$22.4K ﹤0.01% 6118
2024
Q2
Sell
-27,431
Closed -$681K 7542
2024
Q1
$681K Buy
+27,431
New +$680K ﹤0.01% 4604

Other funds holding IBDX

JP Morgan Chase's IBDX Position: Q2 2026 in Review

JP Morgan Chase increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 359% in Q2 2026, buying an estimated $288K and bringing the position to 14,597 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #5279.

JP Morgan Chase first reported a position in IBDX in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.28M in Q3 2025. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • JP Morgan Chase held 14,597 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $369K as of Q2 2026.
  • JP Morgan Chase bought 11,420 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $288K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5279 holding.
  • JP Morgan Chase first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and has held it in 6 quarters since.
  • JP Morgan Chase's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.28M in Q3 2025.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.